NCT01710345View on ClinicalTrials.gov

Safety and Efficacy of Sufentanil NanoTab for Management of Acute Pain Following Bunionectomy

PHASE2CompletedINTERVENTIONAL
Enrollment

101

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
Acute Pain
Interventions
DRUG

Sufentanil NanoTab 20 mcg

DRUG

Sufentanil NanoTab 30 mcg

DRUG

Placebo NanoTab

Trial Locations (2)

Unknown

Lotus Clinical Research, Pasadena

Jean Brown Research, Salt Lake City

All Listed Sponsors
lead

Talphera, Inc

INDUSTRY

NCT01710345 - Safety and Efficacy of Sufentanil NanoTab for Management of Acute Pain Following Bunionectomy | Biotech Hunter | Biotech Hunter